<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03629652</url>
  </required_header>
  <id_info>
    <org_study_id>k(2018)25</org_study_id>
    <nct_id>NCT03629652</nct_id>
  </id_info>
  <brief_title>Head-dOwn Position for ischEmic Stroke With Middle Cerebral Artery (HOPES)</brief_title>
  <acronym>HOPES</acronym>
  <official_title>Head-dOwn Position for ischEmic Stroke With Middle Cerebral Artery (HOPES): a Prospective, Random, Multi-Center, Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Shenyang Military Region</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Shenyang Military Region</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to explore the efficacy and safety of head-down position in patients
      with acute ischemic stroke。
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, the guideline recommended re-perfusion such as intravenous thrombolysis and
      mechanical thrombectomy as the most effective treatment for acute ischemic stroke. However,
      the two methods are restricted by a strict time window, which greatly limits the number of
      the patients receiving treatment. The abundant studies have suggested that good collateral
      circulation can provide compensatory blood supply to save the ischemic penumbra and reduces
      the infarct volume, which improves the prognosis. How to improve collateral circulation in an
      efficient and safe way is a clinical challenge. Our recent experiment results of the animal
      and clinical experiments show that head-down position can significantly increase cerebral
      perfusion and improve neurological function. Clinically, head-down position is simple and
      easy to operate, and theoretically may increases brain perfusion and improve collateral
      circulation. A pilot randomized clinical trial is designed to investigate the effect of
      head-down position combined with routine rehabilitation in patients with ischemic stroke.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 6, 2018</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of patients with modified Rankin Score 0 to 2</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>proportion of patients with modified Rankin Score 0 to 1</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The percentage of reduction in Fugl-Meyer score</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of stroke</measure>
    <time_frame>90 days</time_frame>
    <description>stroke or TIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The percentage of reduction in MMSE</measure>
    <time_frame>90 days</time_frame>
    <description>MMSE，Mini-mental State Examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The percentage of reduction in MoCA</measure>
    <time_frame>90 days</time_frame>
    <description>MoCA, Montreal Congnitive Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major vascular events</measure>
    <time_frame>90 days</time_frame>
    <description>ischemic stroke, hemorrhagic stroke, TIA, myocardial infarction, vascular death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the biggest tolerance time of head-down</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Head down position</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>head-down position treatment combined with conventional rehabilitation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Rehabilitation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Conventional rehabilitation treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>head-down position treatment</intervention_name>
    <description>In the head-down position, the body is in the supine position with the head lowered to 30 degrees</description>
    <arm_group_label>Head down position</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional Rehabilitation</intervention_name>
    <description>The body is in the supine position without lowered head</description>
    <arm_group_label>Conventional Rehabilitation</arm_group_label>
    <arm_group_label>Head down position</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age ≥18 years

          2. acute ischemic stroke within 10 - 30 days of onset

          3. neurological deficit: 6≤NIHSS≤16

          4. Large artery atherosclerosis stroke based on TOAST criteria

          5. The responsibility vessels were the middle cerebral artery or internal carotid artery,
             and the degree of stenosis was more than 50%.

          6. first stroke onset or past stroke without obvious neurological deficit (mRS≤1)

          7. fully understand and cooperate with the doctor's instructions.

          8. the availability of informed consent;

        Exclusion Criteria:

          1. Hemorrhagic stroke or mixed stroke

          2. Combining with severe organ dysfunction

          3. Past hemorrhagic stroke

          4. A history of stroke with severe sequelae

          5. Planning revascularization in 3 months

          6. Ischemic stroke due to surgical intervention

          7. participating in other clinical trials within 3 months

          8. Pregnant or lactating women

          9. any inappropriate patients assessed by the researcher
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hui-Sheng Chen, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital of Shenyang Military Region</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xin-Hong Wang, doctor</last_name>
    <phone>15309885658</phone>
    <email>450341972@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiao-Wen Hou, doctor</last_name>
    <phone>15840240196</phone>
    <email>sophia_hxw@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>General Hospital of ShenYang Military Region</name>
      <address>
        <city>ShenYang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xin-Hong Wang, PhD</last_name>
      <phone>86-24-28897491</phone>
      <email>450341972@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 6, 2018</study_first_submitted>
  <study_first_submitted_qc>August 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>October 24, 2019</last_update_submitted>
  <last_update_submitted_qc>October 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>General Hospital of Shenyang Military Region</investigator_affiliation>
    <investigator_full_name>Hui-Sheng Chen</investigator_full_name>
    <investigator_title>Director of neurological department</investigator_title>
  </responsible_party>
  <keyword>head-down position</keyword>
  <keyword>ischemic stroke</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

